24.10.2024
The EU-funded "MiCCrobioTAckle" project is set to explore the role of the gut microbiome in cancer-related cachexia and develop new treatment strategies. Coordinated by the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), the project will also provide advanced training for 12 PhD candidates, shaping future leaders in microbiota medicine.23.10.2024
The "German Competence Centre for Competitive Sports and Cancer" (KLiK) was founded at the Centre for Integrated Oncology at the University Hospital of Cologne (CIO) in cooperation with the German Sport University, offering specialized advice and support to competitive athletes with cancer.18.10.2024
A study by researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, UC San Diego Health, and other collaborating centers suggests that a simple mouthwash-based test could help predict the recurrence of head and neck cancers.16.10.2024
A research team at University College London (UCL) has developed a new handheld scanner that generates detailed 3D photoacoustic images in just seconds. The device shows potential for clinical use, particularly in diagnosing conditions such as cancer, cardiovascular disease, and arthritis.20.09.2024
Rice University bioengineers have harnessed the lotus leaf's unique properties to create a cutting-edge platform for culturing cancer cell clusters. This system offers a new approach to studying tumor progression and metastasis, providing essential insights into cancer biology and treatment.16.09.2024
A new AI-based digital platform, developed by a research team at the University Hospital of Cologne, enables rapid and precise analysis of lung cancer tissue sections. The platform, which is based on advanced algorithms, could significantly improve the quality of diagnostics and provide new insights into the treatment of lung cancer.30.08.2024
As part of the international “PAINLESS” project, researchers at the University Medical Center Göttingen (UMG) have developed a non-invasive brain stimulation method for treating pain in cancer patients.22.08.2024
A new study by the Paul Scherrer Institute (PSI) and the Massachusetts Institute of Technology (MIT) shows how artificial intelligence (AI) can improve the categorisation of breast cancer stages.16.08.2024
A recent study led by researchers at the Medical University of Vienna has identified the AF1Q gene as a significant biomarker for predicting the risk of gastric cancer relapse. This discovery could enhance personalized treatment strategies and improve survival rates for patients. The study was published in Scientific Reports.09.08.2024
Researchers at the USC Viterbi School of Engineering have developed advanced ingestible sensors that utilize AI and wearable electronics to provide real-time 3D monitoring of gastrointestinal health. These innovative smart pills can detect stomach gases and track their location within the body, offering potential for early disease detection.08.08.2024
A team of engineers and scientists at the University of Notre Dame has developed a wireless LED device that can be implanted to treat deep-seated cancers. This device, when combined with a light-sensitive dye, not only destroys cancer cells but also activates the immune system to target the cancer. The research findings were published in Photodiagnosis and Photodynamic Therapy.30.07.2024
Liquid biopsies in the form of blood tests offer the possibility of analyzing circulating free DNA in the blood and thus improving cancer therapies. The advantage of diagnostics using blood tests is that they can help to detect tumors at an early stage and efficiently monitor the progression of cancer.26.07.2024
Autonomous robotic ultrasound systems can perform routine examinations and support doctors in the operating room. Prof. Nassir Navab from the Technical University of Munich (TUM) is researching these technologies and demonstrating their potential for everyday medical practice.16.07.2024
Cervical cancer is the fourth most common malignant tumor disease in women worldwide. New research results from a comparative study lasting almost ten years show that total mesometrial resection (TMMR) practiced at Leipzig University Medicine has significant advantages over standard treatment.10.07.2024
Researchers at the Max Planck Institute for Biological Cybernetics have developed a new method for cost-efficient medical imaging. This method combines low-field magnetic resonance imaging (MRI) with hyperpolarization and artificial intelligence to improve image quality.03.07.2024
Hannover Medical School (MHH) is leading the RACOON-RESCUE project, which aims to open up new diagnostic possibilities for non-Hodgkin's lymphomas in children and adolescents with the help of automated image data analysis from CT and MRI. The project, led by Prof. Diane Renz, aims to determine disease stages more precisely and optimize therapy follow-up.02.07.2024
The introduction of artificial intelligence (AI) into medical diagnostics has brought about transformative changes, particularly in the early detection of breast cancer. One innovative solution: Transpara.12.06.2024
A team at the University Hospital Bonn (UKB) has established a modern method for the cryopreservation of ovarian tissue known as vitrification. This technique is used to preserve fertility before cancer therapies.28.05.2024
Chimeric Antigen Receptor T (CAR T) cells are a breakthrough in immunotherapy, offering hope for blood cancer patients who have exhausted other options. These genetically modified cells are designed to attack cancer cells by recognizing specific antigens. The therapy has shown promise, particularly in treating B-cell leukemias and lymphomas.30.04.2024
MRI-integrated proton therapy (MRiPT) marks a significant advance in cancer treatment by increasing the precision of radiation treatment. In an interview with MEDICA.de, Prof. Aswin Hoffmann presents current technological challenges and highlights the potential benefits of real-time MRI imaging for proton therapy.22.04.2024
New developments at the Fraunhofer Institute for Material and Beam Technology IWS and partners enable improved research possibilities for cancer therapy using microphysiological systems.12.04.2024
A new medical technique utilizing magnet-guided microrobots for treating liver tumors has been developed by a Canadian research team, offering a potential new approach in oncology.08.04.2024
In a study by Linköping University, an AI-based mobile app has shown high precision in diagnosing skin melanoma, offering new hope for early detection. This research marks a significant step forward in utilizing artificial intelligence (AI) for health diagnostics in primary care settings.04.04.2024
The Raman sensor system opens new monitoring possibilities by precisely measuring the concentration of carotenoids in the skin - a potential indicator of health. This technology offers a non-invasive insight into dietary habits and health status, with the potential to monitor the effectiveness of chemotherapies.22.03.2024
Researchers at Chalmers University of Technology unveil an AI model capable of detecting lymphatic cancer with 90 percent accuracy, improving medical imaging analysis. This new technology promises to enhance diagnostic capabilities and streamline patient care.15.03.2024
Portuguese researchers from the Institute for Systems and Computer Engineering, Technology and Science (INESC TEC) and the IMP Diagnostics Molecular & Anatomic Pathology laboratory have unveiled the world's first prototype applying Artificial Intelligence (AI) to colorectal diagnosis.01.03.2024
Gastrointestinal cancers (GCs) pose a significant health challenge worldwide, with early detection being crucial for effective treatment and improved survival rates. To address this need, scientists have developed a new imaging device aimed at enhancing the accuracy and accessibility of GC screening programs.20.02.2024
Cancer patients often suffer from fatigue syndrome as a side effect. This makes it difficult to cope with everyday life and is usually treated with physiotherapy and behavioral therapy. In the future, an anti-fatigue app should enable treatment to be individually tailored to the person.13.02.2024
In a new development, NTU Singapore researchers have introduced PINN, a state-of-the-art computer program that utilizes AI and heat-imaging technology to detect early breast cancer swiftly and accurately.22.12.2023
In the future, a little saliva may be enough to detect an incipient cancer. Researchers at the University of Gothenburg have developed an effective way to interpret the changes in sugar molecules that occur in cancer cells.21.12.2023
The University Hospital Zurich, the University of Zurich and the diagnostics company Roche are expanding their collaboration in cancer research. In the fully digitalized Morphomolecular Pathology Laboratory, they are developing algorithms that can further improve the effectiveness of immunotherapies.20.12.2023
Together with partners from science, industry and the healthcare sector, the project team led by the Fraunhofer Institute for Cell Therapy and Immunology IZI aims to develop a virtual twin that will improve treatment with personalized cancer immunotherapies in the future.13.12.2023
The use of AI makes it possible for women with a high risk of breast cancer to be identified in mammography screening examinations so that the cancer can be caught earlier. An international research group led from Karolinska Institutet in Sweden can now show that the method is effective in different European countries.07.12.2023
A new method for examining tissue samples could change the way we diagnose and treat cancer. Researchers at the Max Planck and Fraunhofer IPA have developed an automated system based on the principle of enzyme-free tissue processing and the mechanical deformability of individual cells.23.11.2023
Researchers from Göttingen and Karlsruhe have developed a new treatment approach for pancreatic cancer. The innovative method promises to be able to treat the disease in a more targeted way and with fewer side effects in the future. The therapy is now to be optimized for clinical application as quickly as possible.06.11.2023
A Rice University-led collaboration from three continents has won up to a five-year grant from the National Institutes of Health to establish a premier research center in the Texas Medical Center to develop affordable, effective point-of-care (POC) technologies that improve early cancer detection in low-resource settings in the United States and other countries.02.11.2023
An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna investigated the extent to which diagnosis and therapy of pigmented skin lesions benefit from it in a realistic clinical scenario.01.11.2023
The University Medical Center Göttingen (UMG) is coordinating the development of a new nanoparticle-based method for the personalized therapy of patients suffering from colon cancer.03.10.2023
With the ability to map dozens of biomarkers at once, a new method could transform testing for conditions including heart disease and cancer.02.10.2023
A new clinical and research partnership has created an AI model that can predict whether or not cancerous tissue has been fully removed from the body during breast cancer surgery.28.09.2023
BioMagnetix uses bacterial magnetic nanoparticles as innovative materials for biomedical applications. The founding team aims to develop and continuously improve high-quality and highly functional magnetic nanoparticles for imaging techniques and therapeutic purposes, such as cancer treatment.27.09.2023
An international team of scientists has created the first comprehensive index of human cells, mapping the sizes and abundance of all cell types across the entire body.18.09.2023
A group of researchers at the Technical University of Munich (TUM) has developed the world’s first microrobot (“microbot”) capable of navigating within groups of cells and stimulating individual cells.15.09.2023
One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital Health.11.09.2023
When fighting disease, our immune cells need to reach their target quickly. Researchers at the Institute of Science and Technology Austria (ISTA) now discovered that immune cells actively generate their own guidance system to navigate through complex environments.06.09.2023
Linnaeus University is partnering with industry and healthcare to develop advanced biosensors, investing SEK 35 million in a project aimed at faster and cost-effective diagnoses of aggressive lung cancer, viral, and bacterial diseases, potentially enabling self-testing at home.05.09.2023
Tübingen T-cell activator offers protection against coronaviruses in immunocompromised patients04.09.2023
MHH molecular physician Professor Dr. Dr. Schambach wants to use genetically modified natural killer cells to find new therapeutic options against three particularly malignant cancers. The EU is funding the project with 3.8 million euros31.08.2023
A joint team of researchers from the Max Planck Institute for Biology Tübingen and the University Hospital Tübingen has now developed and tested a new computational method to greatly speed up the necessary energy calculations.25.08.2023
A new study highlights the potential of artificial DNA structures that, when fitted with antibodies, instruct the immune system to specifically target cancerous cells.22.08.2023
The complete removal of malignant tumors is a decisive factor for the success of cancer treatment. Until now, the tissue examinations required for this have been time-consuming. In the future, sensor-based methods could come into play to help surgeons detect tumor boundaries more accurately and thus perform a more precise operation.17.08.2023
Researchers discovered that the consistency of a tumor can have a decisive influence on the further course of cancer.11.08.2023
Mammography screening supported by artificial intelligence (AI) is a safe alternative to today’s conventional double reading by radiologists and can reduce heavy workloads for doctors.10.08.2023
JAIST researchers create liquid metal nanoparticles (PEG-IMIQ-LM) for cancer treatment, merging photothermal therapy and immunotherapy. Disintegration delivers immunomodulants and tracks cancer cells in real-time. Immune checkpoint inhibitor enhances cancer removal. Promising for future cancer theranostics, with clinical trials anticipated in a decade.02.08.2023
An international research team led by Harald Kittler of MedUni Vienna has now explored a learning method in which greater accuracy in AI results can be achieved by incorporating human decision-making criteria.26.07.2023
A team of researchers from the Paul Scherrer Institute PSI and ETH Zurich, together with the Baden Cantonal Hospital (KSB) and the University Hospital Zurich (USZ), has succeeded in refining mammography, x-ray imaging technique used to detect tumours in their early stages, to produce considerably more reliable results and be less unpleasant for the patient.24.07.2023
Researchers from Heidelberg University Hospital and the University of Lucerne as well as international scientists, patient representatives and European cancer societies have pooled scientific data and their expert knowledge on the surgical management of lymph nodes in breast cancer.14.07.2023
KIMM develops the world’s first 3D bioprinting technology that enhances the function of NK immune cells. The new technology is expected to improve effectiveness of cancer treatment.12.07.2023
The DECADE research project is the first to use swarm learning in cancer research. The German Cancer Aid is funding the joint project of several university hospitals with around 1.5 million euros.11.07.2023
If a tumor is diagnosed, tissue samples are usually investigated to determine the molecular tumor profile for personalized cancer treatment. However, tissue biopsy cannot be performed in all affected individuals. Therefore, the University Hospital Zurich has licensed a liquid biopsy for the analysis of more than 300 genes and offers this test as a modern diagnostic method to tumor patients.06.07.2023
Using the internal clock to optimize chemotherapies in cancer treatment - that is the goal of the start-up TimeTeller. If the drugs are administered at the ideal time of day for chemotherapy, it can reduce side effects and improve the effect. TimeTeller has developed a method for determining the internal clock to make this possible.30.06.2023
The number of cases of skin cancer is continuing to rise sharply, in Sweden and internationally, involving high costs for a healthcare economy that is already under severe strain in many places. Eva Backman and her team studied the efficacy of treatment options.29.06.2023
The study demonstrates a significant improvement in predicting the response to therapy in metastatic renal cell carcinoma by incorporating the level of inflammation, which was assessed using two straightforward blood parameters, alongside the conventional imaging-based approach.27.06.2023
Researchers of the University of Barcelona and the Institute of Bioengineering of Catalonia (IBEC) have identified new biomarkers for non-small cell lung cancer, the most common lung cancer.22.06.2023
Folate-based radiopharmaceuticals can be used in positron emission tomography (PET) imaging to detect folate receptors in brain tumours. The discovery of folate receptors and their exploitation potential with respect to brain tumours is a new and significant finding in the field.21.06.2023
Two new assistant professors at the University of Bonn are setting out to develop “mini-organs” in order to study metabolic and disease mechanisms.07.06.2023
A Munich research team has developed an algorithm that predicts the effects of genetic mutations on RNA formation six times more precisely than previous models.01.06.2023
Thanks to the radiation they emit, radioactive compounds are suited both to imaging and treating cancers. By appropriately combining them in novel, so-called radionuclide theranostics, both applications can be dovetailed.24.05.2023
The Hannover Medical School (MHH) enters into a clinic partnership with Uzbekistan and supports with a training program for sonography diagnostics of hepatocellular carcinoma (HCC).22.05.2023
The bacteria present in the intestine provide information about the quantities of fungi of the potentially disease-causing Candida genus.18.05.2023
A new advanced artificial intelligence (AI) system has shown world-leading accuracy and speed in identifying protein patterns within individual cells.05.05.2023
Despite approved treatments being available, multiple myeloma remains incurable. But researchers at ETH Zurich and University Hospital Zurich set out to improve treatment outcomes by testing hundreds of existing therapeutics outside the body to predict their effectiveness.03.05.2023
New research has identified a potential therapeutic target and developed a unique delivery system to treat osteosarcoma, a bone cancer that primarily affects children and adolescents.24.04.2023
Under the leadership of the Leibniz Institute for Plasma Science and Technology (INP), the international doctoral candidates network PlasmACT is investigating the use of medical gas plasma technology as a treatment method.19.04.2023
A novel robotic bronchoscope system can non-intrusively access the area of interest within the lung for minimally invasive pulmonary lesions sampling, the gold standard of lung cancer diagnoses.14.04.2023
Chemotherapy treatments produce strong side effects. A new agent that accumulates in the tumour tissue and is activated there by ultrasound waves does not have this problem.10.04.2023
Ioana Slabu from the Institute of Applied Medical Technology and Benedict Bauer from the Institut für Textiltechnik of RWTH Aachen University have developed a novel technology for the therapy of hollow organ tumours, which was awarded second place in the RWTH Innovation Award.06.04.2023
A team of experts has designed a microfluidic device called microfluidic dynamic BH3 profiling (μDBP) that predicts the effectiveness of cancer treatment quickly and automatically.06.04.2023
Surrey scientists have developed a proof-of-concept test called PANDORA that was shown to be over 92% accurate at identifying patients with oral squamous cell carcinoma (OSCC). The test was also shown to be more than 80% accurate at identifying patients with pre-cancer or oral epithelial dysplasia (OED).27.03.2023
Rice University researchers developed an upgraded tumor model that houses osteosarcoma cells beside immune cells known as macrophages inside a three-dimensional structure engineered to mimic bone. Using the model, bioengineer Antonios Mikos and collaborators found that the body’s immune response can make tumor cells more resistant to chemotherapy.23.03.2023
Preliminary stages of cervical cancer occur mainly in women between 25 and 35 years of age. The main risk factor for developing cervical cancer is the human papillomavirus (HPV). Surgery is the treatment of choice.22.03.2023
UWS School of Computing Engineering and Physical Sciences are developing breakthrough investigations into advanced radiation treatment technique, after receiving funding from Cancer Research UK RadNet – the charity's radiation research network.20.03.2023
Unlike other forms of blood cancer, acute myeloid leukemia (AML) cannot currently be treated with CAR-T cell immunotherapy. The reason is that specific molecular targets with which certain immune cells could specifically target AML cells are lacking, which would permit the immune system to attack cancer.17.03.2023
A new ultrasound method that can measure the level of tension in human tissue for the first time - a key indicator of disease - has been developed by researchers from the University of Sheffield.14.03.2023
The technological basis is a proprietary platform technology for the discovery of drugs that target cancer-causing protein-protein interactions (PPIs).09.03.2023
Developing methods to predict the nature of the tumor microenvironment is the goal of researchers from the Clusters of Excellence ImmunoSensation2 and the Hausdorff Center for Mathematics (HCM) led by Prof. Kevin Thurley at the University of Bonn.06.03.2023
The recently launched QEED project aims to significantly reduce measurement time in clinical cancer diagnostics by developing a spectrally resolved imaging technique based on entangled photon pairs. FBH scientists will develop the required diode lasers and quantum light modules.23.02.2023
Researchers at the Centre for Protein Diagnostics PRODI at Ruhr University Bochum, Germany, are using artificial intelligence in combination with infrared imaging to optimally tailor colon cancer therapy to individual patients.26.01.2023
CAN.HEAL aims to expand the available innovations in cancer prevention, diagnosis and treatment in the Member States in order to improve care for all patients in the EU. The project focuses on measures of personalized medicine. Genomics is an important cornerstone for this.19.01.2023
A pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nearly 50% of patients with inoperable locally advanced liver cancer, can be cured through such an innovative approach.17.01.2023
For the first time, a study conducted by a research group at the Comprehensive Cancer Centre Vienna of MedUni Vienna and Vienna General Hospital using data from the multicentre EMBRACE-I trial demonstrated the superiority of a targeted approach in brachytherapy.13.01.2023
Two Dresden research institutes want to reduce the number of animal experiments in radiopharmaceutical research with a new idea.10.01.2023
Researchers at the National Center for Hereditary Tumor Diseases (NZET) at Bonn University Hospital (UKB) have now found that artificial intelligence (AI) can improve the effectiveness of colonoscopy in the presence of Lynch syndrome.06.01.2023
A new tool to identify small molecules offers benefits for diagnostics, drug discovery and fundamental research. A new machine learning model will help scientists identify small molecules, with applications in medicine, drug discovery and environmental chemistry.04.01.2023
License agreement and joint development: Fraunhofer MEVIS commences cooperation with Israeli partner for worldwide use of innovative software technology in ultrasound-aided tumor ablation.22.09.2022
Breast cancer diagnosis usually includes invasive testing with tissue biopsies. The samples have to be extracted from the cancerous tissue or cells. To make the process easier on the patients, the project LIBIMEDOTS is currently developing a different approach with liquid biopsy technology.08.09.2022
Proteins are frequently called the building blocks of life because they are found everywhere, including in our cells. This makes them an important factor when it comes to diseases. As a result, mapping the protein landscape can be a crucial ally in the fight against diseases. Now, a German-Danish team has developed a method that provides researchers with unprecedented insights into cancer.01.08.2022
Artificial intelligence (AI) is about to become a game changer, especially in diagnostics. However, there are still limits to the use of AI. Dr. Altuna Akalin had to recognize this as well. The head of the Max Delbrück Center's (MDC) technology platform for "Bioinformatics and Omics Data Science" developed "ikarus" with his team.01.08.2022
Doctors have always used symptoms, imaging, and laboratory data to define and diagnose diseases, but at times it is simply not enough: while patients may have the same illness, it may exhibit different changes at the molecular level. A team from the Technical University of Munich has developed the so-called MoSBi algorithm and makes it available to researchers to identify molecular differences.01.08.2022
Most laboratory tests only produce small amounts of data that are already sufficient for successful diagnosis. It becomes more difficult with genetic questions: whether it is about a genetic disease or the properties of tumors, there are large amounts of data that must be considered. Both research and medicine need help to identify the connections and patterns in the data to find a diagnosis.28.10.2021
Cervical cancer is one of the most common diseases of the female reproductive organs. Human papilloma viruses are almost always responsible for cervical cancer and the corresponding precancerous lesions. As part of the statutory preventive medical check-up, women from the age of 20 can have a cell smear taken from the cervix once a year, the so-called Pap test, to detect cell changes.08.09.2021
Focused ultrasound waves create microbubbles in a fluid – a phenomenon called cavitation. In a current study, this process is used to destroy liver tumors and metastases.16.07.2021
Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men. Early detection is key to successful treatment, but men often dodge the doctor, avoiding diagnosis tests until it is too late.01.02.2021
In theory, autonomous medical technologies can be used in a diagnostic or therapeutic capacity inside the body under certain conditions. This may not sound like a new invention at first. After all, implantable cardioverter-defibrillators have monitored and fixed abnormal heart rhythm for many years.01.02.2021
Drugs always have undesired side effects. Cytostatics are powerful drugs used to treat cancer. They reach almost all cells in the body, killing healthy cells as well as cancer cells in the process. A targeted delivery to the specific cellular site would be a gentler treatment.08.08.2019
After their tumor has been removed, some patients have to return to the hospital to undergo surgery again. That's because the tumor was not precisely identified and was subsequently not completely removed. That's both an ethical and financial dilemma. A new surgery-adjacent procedure is designed to rapidly and accurately detect tumors.17.06.2019
Medical imaging techniques have developed considerably in recent decades. In addition to morphological imaging techniques more and more functional imaging techniques are used in oncology that can continously record the functions of specific organs locally and regionally in real time. These are groundbreaking for diagnostics, therapies and preoperative preparations.13.02.2019
In conventional radiotherapy, the tumor is first localized using CT and MRT images in order to calculate the irradiated areas. The major drawback in this case: the subsequent radiation only shows bone structures in the body but not the tumor itself. As a result, the radiated area is often larger than necessary. In our video you will learn how the MR-Linac can be used for more precise radiotherapy.